These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 2702030

  • 1. [Mechanisms of progression of glomerular sclerosis in chronic renal diseases in man].
    Garini G, Allegri L, Arisi L.
    Ann Ital Med Int; 1989; 4(3):184-94. PubMed ID: 2702030
    [Abstract] [Full Text] [Related]

  • 2. Progression of chronic renal disease.
    Klahr S.
    Nutrition; 1990; 6(3):207-12. PubMed ID: 2135999
    [Abstract] [Full Text] [Related]

  • 3. The progression of renal disease.
    Klahr S, Schreiner G, Ichikawa I.
    N Engl J Med; 1988 Jun 23; 318(25):1657-66. PubMed ID: 3287163
    [Abstract] [Full Text] [Related]

  • 4. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.
    Brenner BM, Meyer TW, Hostetter TH.
    N Engl J Med; 1982 Sep 09; 307(11):652-9. PubMed ID: 7050706
    [No Abstract] [Full Text] [Related]

  • 5. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
    Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S.
    Hypertens Res; 2008 Mar 09; 31(3):433-41. PubMed ID: 18497462
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The progression of chronic renal disease: immunological, nutritional and intrinsic renal mechanisms.
    Drukker A.
    Isr J Med Sci; 1997 Nov 09; 33(11):739-43. PubMed ID: 9434811
    [Abstract] [Full Text] [Related]

  • 8. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct 09; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 9. Effects of calcium channel blockers on experimental glomerular injury.
    Dworkin LD.
    J Am Soc Nephrol; 1990 Sep 09; 1(3 Suppl 1):S21-7. PubMed ID: 16989074
    [Abstract] [Full Text] [Related]

  • 10. Influence of dietary protein/calorie intake on renal morphology and function in cats with 5/6 nephrectomy.
    Adams LG, Polzin DJ, Osborne CA, O'Brien TD, Hostetter TH.
    Lab Invest; 1994 Mar 09; 70(3):347-57. PubMed ID: 8145529
    [Abstract] [Full Text] [Related]

  • 11. [Factors of progression and chronic renal insufficiency and their prevention].
    Ronco P.
    Bull Acad Natl Med; 1999 Mar 09; 183(1):65-77. PubMed ID: 10371766
    [Abstract] [Full Text] [Related]

  • 12. Early diagnosis of CKD and its prevention.
    Amaresan MS, Geetha R.
    J Assoc Physicians India; 2008 Jan 09; 56():41-6. PubMed ID: 18472500
    [Abstract] [Full Text] [Related]

  • 13. Renal reserve in patients with high blood pressure.
    Gabbai FB.
    Semin Nephrol; 1995 Sep 09; 15(5):482-7. PubMed ID: 8525152
    [Abstract] [Full Text] [Related]

  • 14. Mammalian target of rapamycin inhibition prevents glomerular hypertrophy in a model of renal mass reduction.
    Rovira J, Arellano EM, Carreras J, Campos B, Vodenik B, Bañón-Maneus E, Ramírez-Bajo MJ, Moya-Rull D, Solé-González A, Hernández A, Revuelta I, Quintana LF, Howat WJ, Campistol JM, Diekmann F.
    Transplantation; 2009 Sep 15; 88(5):646-52. PubMed ID: 19741461
    [Abstract] [Full Text] [Related]

  • 15. Effect of the antiglucocorticoid RU-486 on glomerular hemodynamics in remnant nephrons.
    Cardoso LR, Oliveira AV, Santos OF, Boim MA, Razvickas CV, Ajzen H, Schor N.
    Exp Nephrol; 1997 Sep 15; 5(3):217-24. PubMed ID: 9208281
    [Abstract] [Full Text] [Related]

  • 16. [The kidney failure of Bourneville's tuberous sclerosis: a new form of glomerular damage as a result of hyperfiltration?].
    Schillinger F, Montagnac R, Grapin JL, Birembaut P, Hopfner C.
    Nephrologie; 1985 Sep 15; 6(5):219-23. PubMed ID: 4094635
    [Abstract] [Full Text] [Related]

  • 17. Assessment of structure and function in progressive renal disease.
    Agodoa L, Eknoyan G, Ingelfinger J, Keane W, Mauer M, Mitch W, Striker G, Wilcox C.
    Kidney Int Suppl; 1997 Dec 15; 63():S144-50. PubMed ID: 9407444
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of hypertension in renal parenchymal diseases].
    Iversen BM, Kvam FI, Svarstad E.
    Tidsskr Nor Laegeforen; 1996 Jun 30; 116(17):2022-6. PubMed ID: 8766645
    [Abstract] [Full Text] [Related]

  • 19. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun 30; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

  • 20. Effect of diet on progression of chronic renal disease.
    Ahmed FE.
    J Am Diet Assoc; 1991 Oct 30; 91(10):1266-70. PubMed ID: 1918749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.